Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook
Medpace Holdings Inc. (NASDAQ: MEDP ) stock is trading higher on Thursday on better-than-expected second-quarter financial results and raised its fiscal 2026 guidance. The clinical contract research organization reported earnings of $4.25, beating the consensus of $3.97. The company reported sales of $707.33 million, s